213 results on '"Doroud, Delaram"'
Search Results
2. New insight in molecular detection of Mycobacterium tuberculosis
3. DOE-based process optimization for development of efficient methods for purification of recombinant hepatitis B surface antigen from Pichia pastoris feedstock using Capto adhere resin
4. Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication
5. Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2–11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study
6. A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports
7. Determining buffer conditions for downstream processing of VLP-based recombinant hepatitis B surface antigen using multimodal resins in bind-elute and flow-through purification modes
8. PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals
9. Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial
10. Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019
11. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children
12. Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
13. Encapsulated saponin by ferritin nanoparticles attenuates the murine pneumococcal pneumonia
14. Correction: comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection
15. Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection
16. Assessment of COVID‐19 Vaccine Impact on Women's Menstrual Health within an 18‐Month Follow‐Up.
17. The Protective Effect of Serum Levels of Vitamins C, D, and E and IgG and IgM Antibodies in Individuals Vaccinated Against COVID-19 and Experienced Disease Relapse
18. Lessons from COVID-19 Pandemic: A Successful Policy and Practice by Pasteur Institute of Iran
19. Immunogenicity of mannan derived from Mycobacterium bovis as a promising adjuvant in vaccine BCG.
20. Comparison of the ATP-bioluminescence assay and the standard colony counting method for evaluation BCG products
21. Novel approach to improve vaccine immunogenicity: Mannosylated chitosan nanoparticles loaded with recombinant hepatitis B antigen as a targeted vaccine delivery system
22. Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals
23. Optimal Extraction and Deproteinization Method for Mannoprotein Purification from Kluyveromyces marxianus
24. Prevalence of Enteric Viruses in Raw Seafood Collected from the Retail Shops in Tehran, Iran, 2022–2023.
25. Potential Protectivity of a Conjugated COVID-19 Vaccine against Tetanus.
26. The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID‐19 vaccine regimens.
27. Lessons from COVID-19 Pandemic: A Successful Policy and Practice by Pasteur Institute of Iran.
28. Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study
29. A Landscape on Disorders Following Different COVID-19 Vaccination: A Systematic Review of Iranian Case Reports
30. Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis
31. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children
32. Effect of Saponin Encapsulated by Ferritin Nanoparticles on Fetal Lung Development in Female Mice with Streptococcus pneumonia.
33. Optimal Extraction and Deproteinization Method for Mannoprotein Purification from Kluy veromyces marxianus.
34. Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica
35. Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model
36. The Significant Contribution of Pasteur Institute of Iran to COVID-19 Pandemic Control: A Successful Map over the Obstacles
37. Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
38. Corrigendum to “Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein” [Vaccine 40(20) (2022) 2856–2868]
39. Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19.
40. Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection
41. Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein
42. Cytotoxicity Evalution of Mannan Polysaccharide Purified from Mycobacterium Bovis for Use in Vaccine Formulation as an Adjuvant
43. Safety and Immunogenicity of Anti-SARS-CoV-2 Conjugate Vaccine SOBERANA 02: Phase IIb Clinical Trial
44. Predictive Value Alteration of Laboratory Routine and Ferritin/Transferrin Ratio in Monitoring of COVID-19 Patients
45. Safety and Efficacy of the Two Doses Conjugated Protein-Based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-Dose Combination with SOBERANA-PLUS: Double-Blind, Randomised, Placebo-Controlled Phase 3 Clinical Trial
46. Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19
47. Paromomycin loaded solid lipid nanoparticles: Characterization of production parameters
48. Maternal exposure during organogenesis to chlorpyrifos insecticide induce apoptosis process.
49. Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma.
50. Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment efficiency and particle size
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.